[ESPR] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
22-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -66.39%
YoY- -120.67%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 982 184,474 0 0 0 0 0 -
PBT -61,946 -60,039 -37,891 -28,956 -13,122 -9,457 -9,689 36.21%
Tax 5,165 -74 807 423 287 135 47 118.77%
NP -61,946 -60,039 -37,891 -28,956 -13,122 -9,457 -9,689 36.21%
Tax Rate - - - - - - - -
Total Cost 62,928 244,513 37,891 28,956 13,122 9,457 9,689 36.57%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -6,308.15 -32.55 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -2.26 -2.24 -1.44 -1.28 -0.58 -0.49 -0.63 23.71%
EPS Diluted -2.26 -2.24 -1.44 -1.28 -0.58 -0.49 -0.63 23.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.